Evidence map›Paper›PMID 31764221›Full record

ArticleThe American journal of surgical pathology2020

Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.

Caoimhe Egan, Camille Laurent, Julie C Alejo, Stefano Pileri, Elias Campo, Steven H Swerdlow, Miguel Piris, Wing C Chan, Roger Warnke, Randy D Gascoyne and 4 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of surgical pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 40 citations in OpenAlex.

  1. Mucosa-associated lymphoid tissue lymphoma with monoclonal T-cell expansion.Virchows Archiv : an international journal of pathology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. How I Diagnose Angioimmunoblastic T-Cell Lymphoma.American journal of clinical pathology · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 5 countries.

Caoimhe EganNational Institutes of Health, Bethesda, MD.
Camille LaurentToulouse Center of Research on Cancer-Oncopole, CHU Toulouse, CRCT Inserm U1037, Toulouse, France.
Julie C AlejoNational Institutes of Health, Bethesda, MD.
Stefano PileriEuropean Institute of Oncology, IRCCS-Scientific Institute for Research, Hospitalization and Health Care, Milan, Italy.
Elias CampoHospital Clinic of Barcelona, University of Barcelona, Barcelona.
Steven H SwerdlowDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA.
Miguel PirisJiménez Díaz Foundation University Hospital, Madrid, Spain.
Wing C ChanCity of Hope Medical Center, Duarte.
Roger WarnkeDepartment of Pathology, Stanford University, Stanford, CA.
Randy D GascoyneBritish Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada.
Liqiang XiNational Institutes of Health, Bethesda, MD.
Mark RaffeldNational Institutes of Health, Bethesda, MD.
Stefania PittalugaNational Institutes of Health, Bethesda, MD.
Elaine S JaffeNational Institutes of Health, Bethesda, MD.
National Institutes of Health · USCentre de Recherche en Cancérologie de Toulouse · FRCity Of Hope National Medical Center · USEuropean Institute of Oncology · ITHospital Universitario Fundación Jiménez Díaz · ESSpinal Cord Injury BC · CAUniversitat de Barcelona · ESUniversity of Pittsburgh · US

Funding

Lymphoma Disease Discovery and DefintionZIASC000550 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$16.9M
Hematopathology DiagnosisZIABC011070 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$14.5M
Lymphoma Disease Discovery and DefintionZ01SC000550 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 1996 to 2008
$2.3M
Intramural NIH HHS Z01 SC000550
6 · The paper itself

Abstract

The diagnosis of nodal marginal zone lymphoma (NMZL) can be challenging, with the differential diagnosis including other low-grade B-cell lymphomas, reactive hyperplasia, and even some cases of peripheral T-cell lymphoma (PTCL). PTCL may have a perifollicular growth pattern mimicking NMZL. We and others have noted an atypical distribution of T-follicular helper (TFH) cells in some cases of NMZL. This study was prompted by the diagnosis of NMZL in several cases in which a marked increase of TFH cells, as determined by staining for programmed death-1 (PD1), had prompted suspicion for a diagnosis of PTCL. We analyzed PD1 staining in 48 cases of NMZL to characterize the extent and pattern of the PD1-positive infiltrate. Three main patterns of PD1 staining were identified: follicular pattern (peripheral, n=16; central, n=9; mixed, n=3), diffuse pattern (n=4), and a reduced or normal staining pattern in residual follicles (n=16). A comprehensive analysis of other TFH markers was undertaken in 14 cases with a high content of PD1-positive cells that were confirmed as B-cell lymphoma by clonality analysis. We describe in detail 5 of these cases in which PTCL was an initial consideration. This study illuminates the diverse immunohistochemical patterns encountered in NMZL and highlights a diagnostic pitfall important for diagnostic accuracy.

Indexed as

Cell ProliferationAdultAgedAged, 80 and overBiomarkers, TumorDiagnosis, DifferentialDiagnostic ErrorsEuropeFemaleHumansLymphoma, B-Cell, Marginal ZoneLymphoma, T-Cell, PeripheralMaleMiddle AgedNorth AmericaPredictive Value of TestsBiomarkers, TumorPDCD1 protein, humanProgrammed Cell Death 1 Receptor

Identifiers

PMID31764221
PMCPMC8189156
OpenAlexW2990515258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.